Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
5.42 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.778 | 0.62 | 0.262 | 0.419 | 0.915 | 1.164 | 1.103 | 1.163 | 0.401 | 0.866 | -2.453 | 1.333 | -0.978 | 1.316 |
| Cost of Revenue
| 0.118 | 0.108 | 0.083 | 0.041 | 0.054 | 0.044 | 0.053 | 0.056 | 0.06 | 0.042 | 0.058 | 0.044 | 0.062 | 0.035 |
| Gross Profit
| 0.66 | 0.512 | 0.179 | 0.378 | 0.861 | 1.12 | 1.05 | 1.107 | 0.341 | 0.824 | -2.511 | 1.289 | -1.04 | 1.281 |
| Gross Profit Ratio
| 0.848 | 0.826 | 0.683 | 0.902 | 0.941 | 0.962 | 0.952 | 0.952 | 0.85 | 0.952 | 1.024 | 0.967 | 1.063 | 0.973 |
| Reseach & Development Expenses
| 11.126 | 9.112 | 8.511 | 8.558 | 8.499 | 8.254 | 7.543 | 5.899 | 5.029 | 3.474 | 3.531 | 3.659 | 2.637 | 3.063 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.393 | 5.823 | 4.149 | 6.344 | 5.318 | 4.411 | 0.877 | 0.813 | 2.946 | 2.478 | 0.092 | 0.094 | 0.096 | 0.112 |
| Other Expenses
| 0 | -0.011 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 17.519 | 14.935 | 12.66 | 14.902 | 13.817 | 12.665 | 0.877 | 0.813 | 7.975 | 5.952 | 0.092 | 0.094 | 0.096 | 0.112 |
| Operating Income
| -16.859 | -14.423 | -12.481 | -14.524 | -12.956 | -11.545 | -0.877 | -0.813 | -7.634 | -5.128 | -0.092 | -0.094 | -0.096 | -0.112 |
| Operating Income Ratio
| -21.67 | -23.263 | -47.637 | -34.663 | -14.16 | -9.918 | -0.795 | -0.699 | -19.037 | -5.921 | 0.038 | -0.071 | 0.098 | -0.085 |
| Total Other Income Expenses Net
| 0.879 | 0.96 | -0.337 | 0.293 | -0.031 | -0.28 | -0 | 0.128 | 0.033 | -0.365 | 0.004 | 0.004 | 0.004 | 0.004 |
| Income Before Tax
| -15.98 | -13.463 | -12.818 | -13.316 | -12.046 | -10.94 | -0.877 | -0.686 | -7.847 | -5.729 | -0.088 | -0.09 | -0.092 | -0.108 |
| Income Before Tax Ratio
| -20.54 | -21.715 | -48.924 | -31.78 | -13.165 | -9.399 | -0.795 | -0.59 | -19.569 | -6.615 | 0.036 | -0.068 | 0.094 | -0.082 |
| Income Tax Expense
| 0 | 0.031 | 2.723 | -1.208 | -0.91 | -0.605 | -0.07 | -0.054 | -0.119 | 0.601 | -0.048 | -0.046 | -0.044 | -0.043 |
| Net Income
| -15.98 | -13.463 | -12.818 | -13.316 | -12.046 | -10.94 | -0.877 | -0.686 | -7.847 | -5.729 | -0.088 | -0.09 | -0.092 | -0.108 |
| Net Income Ratio
| -20.54 | -21.715 | -48.924 | -31.78 | -13.165 | -9.399 | -0.795 | -0.59 | -19.569 | -6.615 | 0.036 | -0.068 | 0.094 | -0.082 |
| EPS
| -0.45 | -0.38 | -0.36 | -0.38 | -0.35 | -0.4 | -0.078 | -0.05 | -0.25 | -0.18 | -0.004 | -0.004 | -0.005 | -0.005 |
| EPS Diluted
| -0.45 | -0.38 | -0.36 | -0.38 | -0.35 | -0.4 | -0.078 | -0.05 | -0.25 | -0.18 | -0.004 | -0.004 | -0.005 | -0.005 |
| EBITDA
| -16.785 | -14.349 | -12.409 | -14.746 | -12.852 | -11.194 | -0.877 | -0.813 | -7.949 | -4.715 | -0.092 | -0.094 | -0.096 | -0.112 |
| EBITDA Ratio
| -21.575 | -23.144 | -47.363 | -35.193 | -14.046 | -9.617 | -0.795 | -0.699 | -19.823 | -5.445 | 0.038 | -0.071 | 0.098 | -0.085 |